U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274631) titled 'A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine' on June 10.
Brief Summary: Chronic inflammatory pulmonary diseases, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and interstitial lung diseases (ILD) are characterised by lung inflammation and remodelling. Clinical, functional, microbiological, biological, pathological and prognostic features are highly variable and heterogeneous. Several phenotypes have been described within the same pathology, as similar phenotypic traits between different pathologies, ...